The Newsroom

News and stories from the WVU Eye Institute

Latest News

WVU Eye Institute retinopathy of prematurity clinical trial results in FDA approval

A clinical trial conducted by the WVU Eye Institute for the use of EYELEA, an injection medication, has led to FDA approval for the treatment of retinopathy of prematurity (ROP).

View story→

WVU receives NIH funding to dissect the mechanism of retinal degeneration

Peter Stoilov and Visvanathan Ramamurthy—researchers at the West Virginia University School of Medicine—have spent the last several years collaborating to study proteins called Musashi, the loss of which causes rapid retinal degeneration. Their project recently received its fifth year of funding—$502,444—from the National Eye Institute, a division of the National Institutes of Health.

View story→

WVU Eye Institute offering corneal neurotization

The WVU Eye Institute is the first in the region to offer corneal neurotization, a surgery that reconnects nerves to the eye in order to restore sensation.

View story→

Making untreatable vision problems treatable: WVU receives $11M for visual sciences research center

With a new $11 million grant from the National Institutes of Health, West Virginia University has become just the second university in the country to receive funding for a visual-sciences Center of Biomedical Research Excellence.

Read full story→

For more information or to schedule an appointment, call
855-WVU-CARE or schedule online.